Expect a follow up announcement soon with details of what the FDA’s requirements are. This is where the CEO has to manage expectations across the board and in particular not to demean the FDA if in fact it is a simple administrative matter.
Ann: Update on Investigational New Drug Application, page-16
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
71.0¢ |
Change
-0.010(1.39%) |
Mkt cap ! $90.94M | |||
| Open | High | Low | Value | Volume |
| 73.5¢ | 73.5¢ | 70.5¢ | $48.50K | 66.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28542 | 70.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 71.0¢ | 29910 | 1 |
View Market Depth
| Last trade - 15.27pm 20/06/2025 (20 minute delay) ? |
| AGN (ASX) Chart |